State Street Corp Decibel Therapeutics, Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.08 - $4.79 $12,064 - $27,782	5,800 Added 16.5%	40,960 $123,000
Q4 2022 Feb 14, 2023	BUY	$1.86 - $3.54 $33,480 - $63,720	18,000 Added 104.9%	35,160 $72,000
Q2 2022 Aug 15, 2022	BUY	$1.85 - $4.21 $1,665 - $3,789	900 Added 5.54%	17,160 $72,000
Q1 2022 May 16, 2022	BUY	$2.83 - $5.03 $1,584 - $2,816	560 Added 3.57%	16,260 $49,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $9.04 $103,620 - $141,928	15,700 New	15,700 $121,000
Q2 2021 Aug 16, 2021	SELL	$6.39 - $11.51 $372,013 - $670,089	-58,218 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.56 - $19.9 $614,782 - $1.16 Million	58,218 New	58,218 $661,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.